More answers like this
Grok 4.5Oct 8, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or widespread health crisis, though it is better equipped in some areas than before COVID-19 due to stockpile rebuilds, surveillance expansions, and other investments. Significant gaps in coordination, sustained funding, workforce, supply chains, public trust, and (more recently) certain research and international efforts leave the country vulnerable.[1]

Assessments from independent bodies, government watchdogs, bipartisan commissions, and experts consistently highlight incomplete readiness, even as progress has occurred.

Progress Made (Primarily Post-COVID Under Biden Administration)

•Strategic National Stockpile (SNS) and medical countermeasures: The SNS was heavily depleted early in COVID-19. It has since been restocked substantially—for example, holding roughly 70 times the pre-pandemic number of N95 respirators, 34 times the gloves, 50 times the isolation gowns, and 10 times the ventilators. It has supported responses to H5N1 (bird flu), mpox, and other events by deploying PPE, antivirals, vaccines, and treatments. BARDA (Biomedical Advanced Research and Development Authority) has advanced numerous medical countermeasures, with dozens of FDA approvals over time.[2]
•Surveillance and detection: Major expansions include wastewater surveillance covering a large share of the population (detecting COVID, flu, and other pathogens) and electronic case reporting growing from fewer than 200 healthcare facilities pre-pandemic to over 45,000–48,000 by 2024. Syndromic surveillance covers most hospital EDs. These improve early warning.[3]
•Organizational and planning steps: Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023 for coordination; updated National Biodefense Strategy and Global Health Security Strategy; investments in mRNA platforms (aiming for faster vaccine development, e.g., 100-day goals in some visions); H5N1 vaccine stockpiling and development; and a detailed “roadmap”/playbook left for successors. Global efforts included vaccine donations, Pandemic Fund support, and outbreak responses (Ebola, mpox).[4]
•Other: Improved testing partnerships (“warm bases” with labs), some equity-focused outreach during COVID, and lessons documented by GAO and others for future use. ASPR continues real-world deployments and training.[5]

These steps addressed some acute COVID failures (e.g., PPE shortages, slow testing scale-up) and built platforms that could accelerate response.

Persistent and Critical Gaps

•GAO findings: As of mid-2024, hundreds of recommendations from COVID oversight remained open (e.g., ~220 of 428). HHS leadership and coordination of public health emergencies was added to GAO’s High-Risk List and shows longstanding deficiencies in roles/responsibilities, real-time situational awareness networks (statutorily required since 2006 but incomplete), and interagency exercises/lessons learned. Issues span planning, collaboration, data sharing, communications, and program integrity.[6]
•Bipartisan Commission on Biodefense (2024 National Blueprint): The US remains “dangerously vulnerable.” Biological threats (natural, accidental, or deliberate) are growing. Fragmented efforts, insufficient top-level leadership, and failure to fully implement prior recommendations mean COVID’s toll could have been lower and future events worse. It calls for immediate action across leadership, intelligence, S&T, preparedness, detection, and response—urging a shift from boom-bust funding to sustained “on all the time” posture. Ending pandemics in ~10 years is framed as achievable with full commitment (Apollo-like program).[7]
•Funding and infrastructure shortfalls: Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) projected needs far exceed typical appropriations (multi-billion shortfalls). Chronic underfunding of core public health (e.g., after prior outbreaks like H1N1/Ebola/Zika), workforce shortages/burnout, hospital capacity limits, and supply-chain vulnerabilities (domestic manufacturing gaps) persist. Antimicrobial resistance and inequitable access add risks.[8]
•Trust, communication, and equity: Erosion of public confidence in science/institutions hampers response. Misinformation, vaccine hesitancy (e.g., measles resurgence), and fragmented state/local capacities remain challenges.[1]
•Broader biodefense: Intelligence/attribution, deterrence of deliberate threats, dual-use research oversight, and animal-human interface (One Health) need strengthening. Global interdependence means domestic readiness depends partly on international capacity.

Recent Developments (2025 Onward) and Heightened Concerns

Under the second Trump administration, experts and reports describe rollbacks that risk eroding gains:

•OPPR has been understaffed or effectively dormant for periods (partially restaffed later); NIAID strategic plans have de-emphasized biodefense/emerging infectious diseases/pandemic prep; NIH Centers for Research in Emerging Infectious Diseases closed; mRNA and other countermeasure projects cut or wound down; USAID dissolution and foreign aid freezes impacted global health security/surveillance.[9]
•US withdrawal from WHO (completed ~2026), rejection of UN pandemic preparedness declarations, and reduced international engagement weaken early detection abroad and coordinated response.[10]
•Budget pressures, staff reductions at CDC/HHS, and shifts (e.g., some biodefense funds toward DoD) have raised alarms that “it will take generations to rebuild” and that risk of poor outcomes in the next outbreak is higher. Ongoing events (H5N1 in cattle/poultry with human cases, measles outbreaks, others) test systems amid these changes.[11]
•Some continuity exists via ASPR/SNS (deployments, manufacturing investments, new approvals) and congressional appropriations resisting full cuts, but overall trajectory is viewed by many public health experts as diminishing readiness.[5]

Bottom Line and Path Forward

The US has stronger stockpiles, better data tools, and institutional memory than in early 2020, enabling a potentially faster initial response in some scenarios (e.g., known pathogens with existing countermeasures). However, it is not adequately prepared for a novel, highly transmissible/severe pathogen, a large-scale bioweapon event, or cascading crises involving healthcare overload, economic disruption, and societal strain. Coordination failures, boom-bust funding, workforce gaps, and weakened global ties are recurring themes across GAO, bipartisan, academic, and expert analyses.[12]

Preparedness is a continuous process requiring sustained bipartisan investment, clear leadership (e.g., empowered OPPR or equivalent), full implementation of open recommendations, domestic manufacturing resilience, robust surveillance (including international), public trust-building, and exercises. Threats like H5N1, antimicrobial resistance, and emerging pathogens underscore urgency—experts note a substantial chance of another major pandemic in coming decades. Without reversing recent erosions and closing longstanding gaps, the next crisis risks repeating or exceeding COVID’s human and economic costs.

Citations (12)

  1. 1bmj.comAcademic
    https://www.bmj.com/content/384/bmj.q332

    Backs: “Significant gaps in coordination, sustained funding, workforce, supply chains, public trust, and (more recently) certain research and international efforts leave the country vulnerable.”

  2. 2archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “BARDA (Biomedical Advanced Research and Development Authority) has advanced numerous medical countermeasures, with dozens of FDA approvals over time.”

  3. 3cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “Syndromic surveillance covers most hospital EDs. These improve early warning.”

  4. 4ucsb.eduAcademic
    https://www.presidency.ucsb.edu/documents/fact-sheet-biden-harris-administration-releases-global-health-security-annual-report

    Backs: “Global efforts included vaccine donations, Pandemic Fund support, and outbreak responses (Ebola, mpox).”

  5. 5aspr.govGovernment
    https://www.aspr.gov/news-updates/blog/2025-12/stand-ready-move-fast-save-lives

    Backs: “Improved testing partnerships (“warm bases” with labs), some equity-focused outreach during COVID, and lessons documented by GAO and others for future use. ASPR continues real-world deployments and training.”

  6. 6gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Issues span planning, collaboration, data sharing, communications, and program integrity.”

  7. 7biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Ending pandemics in ~10 years is framed as achievable with full commitment (Apollo-like program).”

  8. 8center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “Chronic underfunding of core public health (e.g., after prior outbreaks like H1N1/Ebola/Zika), workforce shortages/burnout, hospital capacity limits, and supply-chain vulnerabilities (domestic manufacturing gaps) persist. Antimicrobial resistance and inequitable access add risks.”

  9. 9the-scientist.comNot yet classified
    https://www.the-scientist.com/niaid-moves-away-from-biodefense-experts-are-worried-75109

    Backs: “USAID dissolution and foreign aid freezes impacted global health security/surveillance.”

  10. 10nytimes.comNews and mediaquality 0.86
    https://www.nytimes.com/2026/09/25/us/politics/us-rejects-un-declaration-on-preparing-for-pandemics.html

    Backs: “US withdrawal from WHO (completed ~2026), rejection of UN pandemic preparedness declarations, and reduced international engagement weaken early detection abroad and coordinated response.”

  11. 11theguardian.comNews and mediaquality 0.75
    https://www.theguardian.com/us-news/2026/may/17/pandemic-preparedness-after-covid

    Backs: “Ongoing events (H5N1 in cattle/poultry with human cases, measles outbreaks, others) test systems amid these changes.”

  12. 12stimson.orgNonprofits and think tanks
    https://www.stimson.org/2024/prepare-for-the-next-biothreat-now/

    Backs: “Coordination failures, boom-bust funding, workforce gaps, and weakened global ties are recurring themes across GAO, bipartisan, academic, and expert analyses.”